Numinus Wellness (CVE: NUMI) CEO Payton Nyquvest joined Steve Darling from Proactive with news the company has revised their agreement with Eight Capital and Canaccord Genuity, who have now agreed to a bought deal worth 40 million. Nyquvest telling Proactive this a big increase their last offering and he talks about how Numinus plans to utilize that capital as they look to continue to creating safe, evidence-based, accessible psychedelic-assisted psychotherapy to help people heal and be well.
Numinus Wellness sees great demand closing upsized 40-million-dollar bought deal public offering
